Ignite Creation Date:
2024-05-06 @ 3:20 PM
Last Modification Date:
2024-10-26 @ 1:48 PM
Study NCT ID:
NCT04603599
Status:
COMPLETED
Last Update Posted:
2020-11-02
First Post:
2020-10-14
Brief Title:
Relationship of Endometrial Cancer and Serum Soluble L1CAM Level
Sponsor:
Kocaeli University
Organization:
Kocaeli University
Study Overview
Official Title:
Relationship of Endometrial Cancer and Serum Soluble L1CAM Level
Status:
COMPLETED
Status Verified Date:
2020-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this study is to evaluate the effect of serum soluble L1CAM sL1CAM on the diagnosis and prognosis of endometrial cancer This prospective randomized controlled trial will be conducted in patients who have undergone endometrial biopsy and whose pathology results are reported as benign endometrial changes endometrial hyperplasia or endometrial cancer The sL1CAM level between groups will be compared The relationship between prognostic factors and serum sL1CAM will be evaluated in patients with endometrial cancer
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None